We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bernard Scheuble has stepped down as chief executive of German drugmaker Merck KGaA, effective immediately, the company announced last week. Vice Chairman Michael Roemer was named to replace Scheuble as chairman of the executive board.
The FDA has selected agency veteran Kathleen Uhl to head its Office of Women's Health (OWH) -- the position abruptly vacated earlier this year by Susan Wood in the wake of the controversial handling of the emergency contraceptive Plan B.
Acting FDA Commissioner Andrew von Eschenbach has named Boris Lushniak and Jeffrey Shuren co-chairs of the agency’s new Task Force on Pandemic Influenza.